Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARDELYX, INC.ARDX · Entity 4972 | See Remarks | November 21, 2025 | November 25, 2025 |
| Sagimet Biosciences Inc.SGMT · Entity 5273 | Director | June 12, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARDELYX, INC.
Report date November 21, 2025 · Filed November 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 299,895 |
Reported balance
After 2025-11-21 transaction · row 1
1 source rowRow 1 · 2025-11-21 · Sale · Disposed 5,995 · Balance 299,895 F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
Sagimet Biosciences Inc.
Report date June 12, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.48 · Expires 2036-06-11 | Direct | 39,567 |
Reported balance
After 2026-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-12 · Grant · Acquired 39,567 · Balance 39,567 F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 12, 2026 Filed Jun 15, 2026 20:20 UTC | Sagimet Biosciences Inc. SGMT · Entity 5273 | GrantStock Option (Right to Buy) · Derivative | 39,567 | $0.00 Strike: $6.48 | $0.00 |
DisclosureSEC source: 0001104659-26-074047 · tm2617570-3_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,567 Underlying: Series A Common Stock · 39,567 shares Expires 2036-06-11 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:44 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 5,995 | $5.54 | $33,193.72 |
DisclosureSEC source: 0001610717-25-000397 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,895 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2025 Filed Aug 26, 2025 01:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 5,841 | $5.93 | $34,647.06 |
DisclosureSEC source: 0001628280-25-041131 · wk-form4_1756170178.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,890 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 21:36 UTC | Sagimet Biosciences Inc. SGMT · Entity 5273 | GrantStock Option (Right to Buy) · Derivative | 32,250 | $0.00 Strike: $5.33 | $0.00 |
DisclosureSEC source: 0001104659-25-058220 · tm2517621-1_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,250 Underlying: Series A Common Stock · 32,250 shares Expires 2035-06-08 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 20, 2025 Filed May 23, 2025 01:50 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 5,992 | $4.08 | $24,455.75 |
DisclosureSEC source: 0001628280-25-027425 · wk-form4_1747965021.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,731 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:56 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 205,019 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-25-008792 · wk-form4_1740696991.xml · derivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,019 Underlying: Common Stock · 205,019 shares Expires 2035-02-25 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of February 25, 2025, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 22:56 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 136,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-008792 · wk-form4_1740696991.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,723 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 23:53 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 4,291 | $5.62 | $24,128.29 |
DisclosureSEC source: 0001628280-25-007228 · wk-form4_1740181995.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,043 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.601611 to $5.625428, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 23:24 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 7,046 | $4.79 | $33,782.05 |
DisclosureSEC source: 0001628280-24-049049 · wk-form4_1732317858.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,334 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 22:22 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 7,089 | $5.86 | $41,543.67 |
DisclosureSEC source: 0001628280-24-038287 · wk-form4_1724365356.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,380 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:05 UTC | Sagimet Biosciences Inc. SGMT · Entity 5273 | GrantStock Option (Right to Buy) · Derivative | 51,459 | $0.00 Strike: $4.64 | $0.00 |
DisclosureSEC source: 0001104659-24-069626 · tm2416701-1_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,459 Underlying: Series A Common Stock · 51,459 shares Expires 2034-06-04 F1 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 5, 2024, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 21, 2024 Filed May 23, 2024 20:10 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 6,927 | $7.81 | $54,106.80 |
DisclosureSEC source: 0001628280-24-024935 · wk-form4_1716495028.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,469 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,636 shares under the Ardelyx Employee Stock Purchase Plan in February 2024. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 109,687 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · derivative · entry 6 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,313 Underlying: Common Stock · 109,687 shares Expires 2033-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionStock Option (Right to Buy) · Derivative | 110,250 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · derivative · entry 5 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,750 Underlying: Common Stock · 110,250 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 219,937 | $8.88 | $1,952,380.75 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 4 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,760 F1 · price: This transaction was executed in multiple trades in prices ranging from $8.63 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 64,233 | $8.87 | $569,836.64 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,697 F1 · price: This transaction was executed in multiple trades in prices ranging from $8.63 to $9.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 109,687 | $2.75 | $301,639.25 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2024 Filed May 9, 2024 20:03 UTC | ARDELYX, INC. ARDX · Entity 4972 | Exercise / conversionCommon Stock | 110,250 | $0.99 | $109,147.50 |
DisclosureSEC source: 0001610717-24-000235 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:24 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 45,000 | $9.00 | $405,000.00 |
DisclosureSEC source: 0001610717-24-000233 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,993 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023. Read SEC document |
| March 20, 2024 Filed Mar 22, 2024 20:42 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 86,000 | $7.73 | $664,977.80 |
DisclosureSEC source: 0001610717-24-000182 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 312,993 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $7.65 to $7.92, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 21:57 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 4,432 | $8.75 | $38,763.60 |
DisclosureSEC source: 0001610717-24-000083 · form4.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 398,993 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:34 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 164,000 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · derivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,000 Underlying: Common Stock · 164,000 shares Expires 2034-01-16 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 21:34 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 127,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-001680 · wk-form4_1705613639.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 403,425 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 22:44 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 50,000 | $5.08 | $253,925.00 |
DisclosureSEC source: 0001628280-23-041479 · wk-form4_1702507443.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,675 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 24, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $4.99 to $5.27, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 20, 2023 Filed Nov 22, 2023 22:19 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2,384 | $4.36 | $10,399.48 |
DisclosureSEC source: 0001628280-23-039900 · wk-form4_1700691550.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,675 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2,392 | $3.55 | $8,495.91 |
DisclosureSEC source: 0001628280-23-030399 · wk-form4_1692823171.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,059 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · price: This transaction was executed in multiple trades in prices ranging from $3.511 to $3.551843, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 20:15 UTC | Sagimet Biosciences Inc. SGMT · Entity 5273 | GrantStock Option (Right to Buy) · Derivative | 49,533 | $0.00 Strike: $8.74 | $0.00 |
DisclosureSEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,533 Underlying: Series A Common Stock · 49,533 shares Expires 2031-04-19 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| July 18, 2023 Filed Jul 20, 2023 20:15 UTC | Sagimet Biosciences Inc. SGMT · Entity 5273 | Disposition to issuerStock Option (Right to Buy) · Derivative | 49,533 | $0.00 Strike: $8.74 | $0.00 |
DisclosureSEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,533 shares Expires 2031-04-19 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock. F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date. Read SEC document |
| May 23, 2023 Filed May 25, 2023 12:54 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2,384 | $3.65 | $8,709.23 |
DisclosureSEC source: 0001104659-23-064393 · tm2316962-6_4seq1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,451 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Reflects the adjusted total which includes the purchase of 2,881 shares under the Ardelyx Employee Stock Purchase Plan in February 2023. Read SEC document |
| February 21, 2023 Filed Feb 24, 2023 22:39 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2,914 | $3.00 | $8,744.91 |
DisclosureSEC source: 0001567619-23-003772 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,954 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:26 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 351,000 | $0.00 Strike: $2.73 | $0.00 |
DisclosureSEC source: 0001567619-23-000647 · doc1.xml · derivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,000 Underlying: Common Stock · 351,000 shares Expires 2033-01-05 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 5, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 05, 2023 Filed Jan 6, 2023 21:26 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 78,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-000647 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,868 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,193 | $1.95 | $2,325.51 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,868 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 20 | $1.95 | $38.90 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,061 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:16 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 29 | $1.94 | $56.30 |
DisclosureSEC source: 0001567619-22-020849 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,081 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 23:02 UTC | ARDELYX, INC. ARDX · Entity 4972 | PurchaseCommon Stock | 3,000 | $0.62 | $1,856.40 |
DisclosureSEC source: 0001567619-22-016955 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,110 F1 · balance_after: Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2022. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:43 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 9 | $0.98 | $8.82 |
DisclosureSEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,110 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:43 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 2 | $0.98 | $1.96 |
DisclosureSEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,119 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| August 22, 2022 Filed Aug 24, 2022 21:43 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,225 | $0.98 | $1,205.03 |
DisclosureSEC source: 0001567619-22-016643 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,121 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| June 06, 2022 Filed Jun 9, 2022 00:01 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,260 | $0.64 | $800.86 |
DisclosureSEC source: 0001567619-22-012554 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,346 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| June 06, 2022 Filed Jun 9, 2022 00:01 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 59,561 | $0.65 | $38,768.25 |
DisclosureSEC source: 0001567619-22-012554 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,606 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2022 Filed May 23, 2022 20:31 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,263 | $0.67 | $847.98 |
DisclosureSEC source: 0001567619-22-011517 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,167 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 21:56 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 1,528 | $0.67 | $1,023.76 |
DisclosureSEC source: 0001567619-22-005661 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,430 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| January 06, 2022 Filed Jan 13, 2022 00:46 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantStock Option (Right to Buy) · Derivative | 196,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001567619-22-001137 · doc1.xml · derivative · entry 3 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,000 Underlying: Common Stock · 196,000 shares Expires 2032-01-06 F2 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| January 06, 2022 Filed Jan 13, 2022 00:46 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 42,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001137 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,958 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:05 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 537 | $0.99 | $532.65 |
DisclosureSEC source: 0001567619-21-021158 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,958 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| November 12, 2021 Filed Nov 13, 2021 00:09 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 77,432 | $1.13 | $87,111.00 |
DisclosureSEC source: 0001567619-21-020115 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,495 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 28, 2021. F2 · price: The transaction was executed in multiple trades in prices ranging from $1.11 to $1.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 08, 2021 Filed Oct 29, 2021 23:54 UTC | ARDELYX, INC. ARDX · Entity 4972 | GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019028 · doc1.xml · nonDerivative · entry 1 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 353,927 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. F2 · balance_after: Reflects the adjusted total which includes the purchase of 1,541 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 22:05 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 526 | $1.32 | $694.32 |
DisclosureSEC source: 0001567619-21-016282 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,386 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:46 UTC | ARDELYX, INC. ARDX · Entity 4972 | SaleCommon Stock | 508 | $7.09 | $3,600.60 |
DisclosureSEC source: 0001567619-21-010920 · doc1.xml · nonDerivative · entry 2 GRAMMER ELIZABETH A · CIK 0001213041 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,912 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.